Drug Profile
Research programme: antimicrobials - Liponex
Alternative Names: CRD 300Latest Information Update: 25 May 2008
Price :
$50
*
At a glance
- Originator Liponex
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 25 May 2008 Discontinued - Preclinical for Bacterial infections in Canada (unspecified route)
- 27 Mar 2006 Preclinical trials in Bacterial infections in Canada (unspecified route)